18-Oct-2024
Three events that shook health insurers this week
Seeking Alpha News (Sat, 19-Oct 3:08 PM ET)
Humana reportedly sues over Medicare Star Rating cut
Seeking Alpha News (Sat, 19-Oct 1:38 PM ET)
Humana reportedly sues over Medicare Star Ratings cut
Seeking Alpha News (Sat, 19-Oct 1:38 PM ET)
Humana gains amid report of Cigna talks (update)
Seeking Alpha News (Fri, 18-Oct 4:41 PM ET)
Humana gains amid reports of renewed Cigna talks (update)
Seeking Alpha News (Fri, 18-Oct 4:41 PM ET)
Humana goes positive amid takeover speculation
Seeking Alpha News (Fri, 18-Oct 3:08 PM ET)
CVS Health falls after leadership change, Q3 miss (update)
Seeking Alpha News (Fri, 18-Oct 1:14 PM ET)
CVS Health in selloff after leadership change, Q3 miss (update)
Seeking Alpha News (Fri, 18-Oct 1:14 PM ET)
If HUM Price Stays Within $260 to $275 Range This Iron Condor Will Yield 50%
Market Chameleon (Fri, 18-Oct 11:23 AM ET)
CVS Health falls after leadership transition, Q3 earnings miss
Seeking Alpha News (Fri, 18-Oct 7:04 AM ET)
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Humana trades on the NYSE stock market under the symbol HUM.
As of October 18, 2024, HUM stock price climbed to $267.14 with 3,806,562 million shares trading.
HUM has a beta of -0.45, meaning it tends to be less sensitive to market movements. HUM has a correlation of 0.02 to the broad based SPY ETF.
HUM has a market cap of $32.19 billion. This is considered a Large Cap stock.
Last quarter Humana reported $29 billion in Revenue and $6.96 earnings per share. This beat revenue expectation by $860 million and exceeded earnings estimates by $1.11.
In the last 3 years, HUM traded as high as $571.30 and as low as $213.31.
The top ETF exchange traded funds that HUM belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
HUM has underperformed the market in the last year with a return of -48.1%, while the SPY ETF gained +37.5%. In the last 3 month period, HUM fell short of the market, returning -31.1%, while SPY returned +6.1%. However, in the most recent 2 weeks HUM has outperformed the stock market by returning +11.3%, while SPY returned +2.0%.
HUM support price is $258.59 and resistance is $274.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUM shares will trade within this expected range on the day.